Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID07478172

Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults with Neuromuscular Disease

Led by University of Missouri-Columbia · Updated on 2026-03-17

50

Participants Needed

1

Research Sites

1 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating the effects of whole-body electrical muscle stimulation (WB-EMS) exercise on neuromuscular and physical function in adults with neuromuscular diseases (NMD) such as amyotrophic lateral sclerosis, spinal muscular atrophy, and myasthenia gravis. People with NMD often face challenges with traditional exercise because of impaired voluntary muscle activation, which can lead to inactivity and worsening health. WB-EMS bypasses these limits by directly stimulating muscle contractions using electrical currents, potentially offering a new way to exercise safely. The intervention uses the Katalyst system, an FDA-cleared device applied off-label, which delivers electrical stimulation to major muscle groups during guided movements. Participants wear a special suit with electrodes connected to an impulse pack controlled via an iPad app. They complete 20-minute supervised exercise sessions 1-2 times per week for 4-8 weeks, following Level 1 strength training videos. Each exercise involves repetitions with stimulation on and off periods, and stimulation levels are adjusted based on participant responses and comfort. Participants will be monitored carefully throughout the study, with evaluations before and after the intervention including neural excitability (using transcranial magnetic stimulation), motor unit behavior (via electromyography and nerve conduction studies), and functional tests like walking, balance, and strength assessments. Patient-reported outcomes on fatigue, pain, and quality of life will also be collected. Safety monitoring is strict, and the study will provide preliminary data on the feasibility and impact of WB-EMS exercise for adults with NMD.

CONDITIONS

Brief Title

Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Diagnosed with one or more specified neuromuscular conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy, myasthenia gravis, Charcot Marie Tooth disease, and others
  • Able to stand continuously for approximately 15 minutes with or without an assistive device
  • Have at least some anti-gravity strength in major muscle groups (2+/5 strength or better)
  • Medical clearance to participate in an exercise program
  • Ability to provide informed consent
  • Willingness and ability to attend all study visits and maintain current non-study physical activity levels during the study
  • No plans to relocate during the study period
Not Eligible

You will not qualify if you...

  • Diagnosed with neuromuscular conditions involving cardiac issues or muscle fiber structural defects such as Becker's muscular dystrophy or Duchenne muscular dystrophy
  • Currently participating in another interventional research study
  • Unable to tolerate 15 minutes of continuous standing
  • Presence of implanted devices like pacemakers or metal implants that affect safety during WB-EMS
  • Presence of cochlear implants, cortical stimulators, deep brain stimulators, recent skull defects, recent seizures, or previous serious adverse events with TMS
  • Unstable acute or chronic diseases such as renal failure, arrhythmia, or uncontrolled hypertension
  • Known pregnancy at screening
  • Receiving hospice care or diagnosed with a terminal disease
  • Use of drugs affecting muscle mass or performance within the past 6 months
  • Additional neurologic conditions affecting motor or sensory function such as Parkinson's disease or stroke
  • Recent musculoskeletal surgery or conditions that could affect exercise results
  • Other medical conditions that could interfere with study results as determined by investigators

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - 4 to 8 weeks

Participants complete supervised whole-body electrical muscle stimulation exercise sessions, performing 20-minute exercise programs 1 to 2 times per week with monitoring to adjust stimulation levels based on participant responses.

1 to 2 visits per week

Trial Site Locations

Total: 1 location

1

NextGen Precision Health Building, Clinical and Translational Science Unit

Columbia, Missouri, United States, 65211

Actively Recruiting

Loading map...

Research Team

K

Kristina M Kelly, DPT, MS, EdM

W

W. David Arnold, MD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Similar Trials

A Non-interventional, Post-authorisation Safety Study of Pat...

Myasthenia Gravis

Actively Recruiting

35 locations

A Phase 1 Study of Anitocabtagene Autoleucel for the Treatme...

Muscular Diseases

Actively Recruiting

13 locations

A Phase 1b/2 Study of IM-101 to Evaluate Safety, Tolerabilit...

Myasthenia Gravis

Actively Recruiting

25 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here